| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |